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Abstract
Background: Limb girdle muscular dystrophy type 2G (LGMD2G) is a subtype of autosomal recessive muscular
dystrophy caused by mutations in the telethonin gene. There are few LGMD2G patients worldwide reported, and
this is the first description associated with early tibialis anterior sparing on muscle image and myopathic-neurogenic
motor unit potentials.
Case presentation: Here we report a 31 years old caucasian male patient with progressive gait disturbance, and
severe lower limb proximal weakness since the age of 20 years, associated with subtle facial muscle weakness.
Computed tomography demonstrated soleus, medial gastrocnemius, and diffuse thigh muscles involvement with
tibialis anterior sparing. Electromyography disclosed both neurogenic and myopathic motor unit potentials. Muscle
biopsy demonstrated large groups of atrophic and hypertrophic fibers, frequent fibers with intracytoplasmic rimmed
vacuoles full of autophagic membrane and sarcoplasmic debris, and a total deficiency of telethonin. Molecular
investigation identified the common homozygous c.157C > T in the TCAP gene.
Conclusion: This report expands the phenotypic variability of telethoninopathy/ LGMD2G, including: 1) mixed
neurogenic and myopathic motor unit potentials, 2) facial weakness, and 3) tibialis anterior sparing. Appropriate
diagnosis in these cases is important for genetic counseling and prognosis.
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Background
Limb girdle muscular dystrophy 2G (LGMD2G) is a sub-
type of autosomal recessive muscular dystrophy caused
by mutations in the telethonin (TCAP) gene, character-
ized by a progressive limb girdle muscular weakness. Its
progression rate has been considered relatively slow,
compared to other muscular dystrophies [1]. There is a
worldwide small number of known patients with teletho-
ninopathy, either with limb girdle muscular dystrophy
2G [2-9] or with congenital muscular dystrophy [1,10,11].
The number of publications with image studies in
LGMD2G patients is even smaller [7,8,12].
The aim of this study is to present clinical, neuro-
physiologic, laboratorial, muscle morphologic, immu-
nohistochemical and electron microscopy analyses and
molecular findings in a newly identified patient with
LGMD2G, revealing a higher phenotypic variability. This
is the first report of a telethoninopathy patient with early
tibialis anterior muscular sparing on image study, facial
weakness, myopathic/neurogenic motor unit potentials,
and ultrastructural study of the rimmed vacuoles on
muscle biopsy [2-12].
Case presentation
Patient information
A 29 years old male patient was admitted at the out-
patient clinic. He reported frequent falls since gait acqui-
sition when he was one year old. After 20 years old, he
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noticed progressive gait disturbance with weakness in
the lower limbs and tremor on the hands. No history of
parental consanguinity or similar cases in the family
were reported. Physical examination at admission re-
vealed increased calf, difficulties performing extraocular
eye movement and lower limb proximal weakness.
Clinical findings
Clinical examination, included muscle strength testing
as rated by the Medical Research Council scale. The de-
gree of muscle involvement on image studies was evalu-
ated according to a 5-point scale [13,14]. Stage 0 is
normal appearance; stage 1 (mild) corresponds to traces
of decreased density on CT (computed tomography)
or increased signal intensity on the T1-weighted MR
(magnetic resonance) sequences; stage 2 (moderate) re-
flects reduced density on CT or increased signal intensity
(MRI) with beginning confluence in less than 50% of the
muscle; stage 3 (severe) refers to decreased density (CT)
or increased signal intensity (MRI) in more than 50% of
an examined muscle; and stage 4 (advanced disease) to a
state when the entire muscle is replaced by lower density
(CT) or increased signal intensity (MRI).
Diagnostic assessment
Electromyography (EMG) disclosed a mixed pattern,
neurogenic and myopathic, mainly myopathic, with mild
muscle membrane hyperexcitability. We analyzed the
right deltoideus, triceps, biceps brachialis and first dorsal
interosseous, left vastus lateralis, bilateral tibialis anterior
and right gastrocnemius medialis by conventional and
quantitative EMG method with twenty motor unit po-
tentials (MUP) quantification of each muscle studied. At
rest, fibrillation and positive waves were detected in the
right gastrocnemius medialis. At initial effort, all muscles
studied showed low amplitude and/or short duration MUP
(myopathic characteristics), mainly in the lower limbs.
Right triceps brachialis, deltoideus and first dorsal inter-
osseous muscles presented a mixed pattern (myopathic
and neurogenic), showing besides myopathic motor unit
potentials, many other potentials with high amplitude
and/or long duration (neurogenic characteristics), with
high MUP polyphasic proportion in all of them (Table 1).
Serum muscle enzymes were increased with a total
creatine kinase level of 1438 UI/L (7.5×) (reference value
under 190 UI/L), and serum aldolase level of 10.1 (1.3×)
(reference value under 7.6 U/L).
Computed tomography of the pelvis, thighs and legs
revealed advanced gluteus maximus, gluteus medius,
and gluteus minimus involvement. At the thigh, there
was advanced (grade 4) biceps femoris, semitendinosus,
and semimembranosus involvement; severe (grade 3)
vastus lateralis, vastus medialis, vastus intermedius, and
adductor magnus involvement, with relative preservation
and hypertrophy of the sartorius and gracilis. At the leg,
there was asymmetric muscle involvement with ad-
vanced (grade 4) soleus, right gastrocnemius medialis,
and left peroneus involvement, as well as tibialis anterior
muscle sparing (Figure 1).
Patient was submitted, when he was 31 years old, to a
left vastus lateralis muscle biopsy that demonstrated
abnormal architecture with areas of fibrous and fat re-
placement, endomysial fibrosis, fiber splitting, atrophic
and hypertrophic fibers. There were groups of atrophic
and groups of hypertrophic fibers (Figure 2A), with
type 2 fiber predominance (data not shown). Frequent
rimmed vacuoles were observed. These rimmed vacuoles
presented different sizes and shapes, peripheral or central
locations, inside the sarcoplasm of both atrophic and
hypertrophic fibers. Rimmed vacuoles were character-
ized by empty spaces with a rim of basophilic material
(Figure 2B). No lobulated fibers were observed on the
muscle biopsy sample.
Immunohistochemical studies demonstrated normal
reaction for sarcoglycans (alpha, beta, gamma, delta),
dysferlin, merosin, caveolin, myotilin, and emerin. Immu-
nohistochemical studies for the three dystrophin epitopes
(Rod, carboxy-terminus, amino-terminus), disclosed focal
irregular reaction for the carboxy-terminus that was evi-
dent on serial sections of the same fibers (Figure 2D,E,F).
Immunohistochemical reaction for the anti-telethonin
antibody showed total deficiency (Figure 2C), consistent
with telethoninopathy (Limb Girdle Muscular Dystrophy
type 2G).
Transmission electron microscopy demonstrated endo-
mysial fibrosis, fiber and myofiber splitting, focal intrasar-
coplasmic glycogen deposits, many degenerating fibers,
very small atrophic fibers with or without degeneration
signs, and autophagic vacuoles with numerous membrane
and sarcoplasmic debris (Figure 2G,H).
The molecular investigations were part of standard
patient diagnostics, and included the search for Faciosca-
pulohumeral muscular dystrophy, Spinal muscular atrophy,
mitochondrial m.3243 A < G mutation, dystrophino-
pathy, and Limb Girdle Muscular Dystrophy type 2A
(calpainopathy), which disclosed normal results. The FKRP
gene dHPLC followed by direct sequencing to investigate
the hypotheses of Limb Girdle Muscular Dystrophy type 2I
(fukutin-related myopathy) revealed one single het-
erozygous exon 4 c.461G > T, p.(Arg154Phe) mutation
in the FKRP gene with unknown significance. Sequencing
of the 2 exons of the TCAP gene identified the common
c.157C >T (p.Q53X) mutation in homozygous state.
Discussion
The patient here described presented his first symptoms
in childhood and evident lower limb muscular weakness
at 20 years old. His symptoms progression was within
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the age range previously described in telethoninopathy
patients, that is usually between 9 and 20 years old [12].
Differently from other LGMD2G patients, however, he
presented tremor on the hands at his first examination,
which significance in the myopathic context of his dis-
ease is still not clear. Small hand muscle weakness was
slight or inexistent in previously described patients [2].
An additional atypical characteristic of LGMD2G, ob-
served in this patient, was a subtle extraocular and fa-
cial weakness, since facial muscles were always spared
in telethoninopathy patients already reported [2,7,8].
Interestingly, this finding had been observed in another
telethoninopathy Brazilian patient, examined in advanced
stage of the disease [12].
The muscular weakness pattern in telethoninopathy
may be predominant proximal or distal [2-9,12]. Even in
patients with predominant proximal lower limb weak-
ness, foot drop or frequent tripping, related to tibialis
anterior involvement, are common initial [8,12] or late
(ten years after first symptoms) [7] findings. In accor-
dance with these clinical observations, our patient also
presented predominant proximal lower limb weakness,
and calf volume increase with soleus and gastrocnemius
medialis involvement. On the other hand, a pattern of
early tibialis anterior involvement, compared to posterior
calf muscles, on muscle image studies, which has been
consistently reported in teletoninopathy patients [7,8,12]
was absent in this patient.
The electromyography demonstrated mixed neuro-
genic and myopathic motor unit potentials. Muscle bi-
opsy demonstrated groups of atrophic and groups of
hypertrophic fibers simulating a neurogenic pattern.
Neurogenic pattern associated with muscular dystrophy
has already been described in calpainopathy (Limb Girdle
Muscular Dystrophy type 2A - LGMD2A) patients [15,16].
This pattern could be perhaps secondary to a reinnervation
process after fiber group necrosis or nerve degeneration,
Table 1 Quantitative analyses of motor unit potentials in the muscles studied
Muscle N = 20 MUP per muscle Amplitude (μV) Mean (min-max) Duration (ms) Mean (min-max) Polyphase (%)
Right deltoideus 4322 (1221–10000) 6,1 (3,6-10,4) 45
Right triceps 5243 (679–8611) 10,1 (3,6-17,4) 30
Right biceps brachialis 1608 (774–3953) 6,3 (2,8-12,2) 35
Right first dorsal interosseous 5265 (1399–10000) 7,1 (1,8-13,6) 25
Left vastus lateralis 1329 (454–4233) 5,9 (3,4-9,0) 20
Right tibialis anterior 1619 (292–3047) 6,2 (3,4-9,0) 30
Left tibialis anterior 1279 (413–2472) 4,8 (2,2-10,6) 40
Right gastrocnemius medialis NP NP NP
MUP- motor unit potentials; NP- Not performed.
Figure 1 Computed tomography of the pelvis, thighs and legs.
At the pelvis there is advanced gluteus maximus, gluteus medius,
and gluteus minimus involvement. At the thigh, there is advanced
biceps femoris, semitendinosus, semimembranosus involvement;
severe vastus lateralis, vastus medialis, vastus intermedius, and
adductor magnus involvement, with relative preservation and
hypertrophy of sartorius and gracilis. At the leg, there is asymmetric
muscle involvement with advanced right gastrocnemius medialis,
left peroneus, bilateral soleus involvement, compared to tibialis
anterior muscle sparing.
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although neither nerve degeneration nor groups of necrotic
fibers were observed on this muscle biopsy. Therefore, the
exact mechanism of neurogenic motor unit potentials in
this patient remains elusive.
Muscle biopsy, from the patient here reported, demon-
strated the frequent findings of LGMD, including fibers
with rimmed vacuoles, which we well characterized by
transmission electron microscopy, as vacuoles contain-
ing sarcoplasmic degradation products.
Immunohistochemical investigation demonstrated
complete deficiency of telethonin, which is totally indica-
tive of LGMD2G [2-12].
Only a small number of known patients with teletho-
ninopathy have been reported [2-12]. As molecular
diagnosis is not worldwide available, and since a huge
clinical variability can be observed in all forms of
LGMDs, protein techniques with commercially available
anti-telethonin antibodies should be introduced in a rou-
tine basis in the diagnostic workup of any patient with
undetermined limb girdle muscular dystrophy, both with
proximal and distal weakness, and/or myopathic or
mixed neurogenic phenotypes.
Telethonin is a sarcomeric protein that binds to the
titin amino terminus [17], it is involved with normal
sarcomeric regulation and development, activated by
MyoD and expressed after myogenin binding during
embryogenesis [18]. Therefore, it is believed that tele-
thonin does not interact with the dystrophin associated
complex [19]. Thus, the telethoninopathy physiopath-
ological mechanism of fiber injury may be different
from the putative mechanical stress disruption of the
sarcolemma, during muscle contraction, in dystrophi-
nopathy. Perhaps fiber necrosis may be secondary to
a defect in sarcomeric regulation with accumulation
of fiber degradation products and possible lysosomal
hyperactivity.
The patient here described was submitted to muscle
biopsy about eleven years after the progression of
muscle weakness. No lobulated fibers or nemaline rods
were observed on his muscle biopsy, in the opposite
to a patient who was submitted to muscle biopsy
46 years after her first symptoms [12]. Therefore, it is
possible that lobulated fibers and nemaline rods are a
secondary phenomenon related to the long duration of
symptoms [13], not yet manifested in this still ambu-
lant patient.
Conclusions
The phenotypic variability of telethoninopathy is ex-
panded with this report, as it disclosed that: 1) early
tibialis anterior involvement compared to posterior leg
muscles is not mandatory at first presentation, and
2) telethoninopathy may mimic clinical and neurophysio-
logical signs of neurogenic disorders. Later studies will be
necessary to elucidate the physiopathological mecha-
nisms involved in the development of telethoninopathy
as well as the precise mechanism of muscle involvement
and sparing, detectable through clinical examination and
image studies, and the discovery of mechanisms to stop
muscle weakness progression.
Figure 2 Muscle biopsy. (A) Severe variation in fiber calibre, showing
groups of atrophic fibers (arrow) and groups of hypertrofic fibers
(HE 100x). (B) Frequent rimmed vacuoles (arrows) with basophilic
material (HE 400×). (C) Immunohistochemical reaction with complete
telethonin deficiency. Inset presents strong normal sarcolemmal
reaction in control muscle (Antibody anti-telethonin (G-11): sc-25327,
Santa Cruz Biotechnology, Inc., at 1:50 dilution). (D, E, F) Serial frozen
sections of the same muscle fibers (arrows) showing irregular dystrophin
carboxy-terminus reaction (E) (D - Rod-domain anti-dystrophin
antibody (NCLDYS1 Novocastra at 1:20 dilution), E - Carboxy-terminus
anti-dystrophin antibody (NCLDYS2 Novocastra at 1:20 dilution),
F - Amino-terminus anti-dystrophin antibody (NCLDYS3 Novocastra
at 1:20 dilution), (G) Muscle tissue shows autophagic vacuoles
(arrows) with membrane debris and myelinoid figures (transmission
electron microscopy 5000x), (H) Atrophic muscle fiber with myofibrillar
disorganization, and few residual sarcomeres with distinguishable Z
lines (arrows) (transmission electron microscopy 6000x).
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Consent
The study was performed in accordance with the Declar-
ation of Helsinki guidelines. Written informed consent
was obtained from the patient for molecular study, pub-
lication of this Case report and any accompanying im-
ages. A copy of the written consent is available for
review by the Editor of this journal.
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